Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation
Gonzalo Hijos(Instituto de Investigación Sanitaria Aragón), María José Domper-Arnal(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Mercedes Navarro(Hospital Clínico Universitario Lozano Blesa), Enrique Alfaro(Hospital Clínico Universitario Lozano Blesa), Cristina Jimeno(Deleted Institution), Ana Pardillos(Deleted Institution), Pablo Cañamares(Hospital General San Jorge), C. G. Bruno(Boston College), Ángel Lanas(Universidad de Zaragoza), Inés Ariño(Hospital Obispo Polanco), Patricia Carrera‐Lasfuentes(Universidad San Jorge), Marina Asunción Pardina Solano, Mara Charro(Centro de Salud Casa del Barco)
Cited by 2
Related Papers
Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries
|World Journal of Gastroenterology|2015|1k
Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
|Endoscopy|2015|823
Colorectal cancer population screening programs worldwide in 2016: An update
|World Journal of Gastroenterology|2017|633
Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding
|Gastroenterology|1992|211
Non-variceal upper gastrointestinal bleeding
|Nature Reviews Disease Primers|2018|190